Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | STENOCARE Welcomes Danish Health Minister's Decision to Permanently Legalise Medical Cannabis for Patients | 1 | Cision News | ||
05.11. | Stenocare A/S: Interim Report Third Quarter 2024 | 85 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENOSTENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2024 - 30.09.2024. The report, which has not been reviewed... ► Artikel lesen | |
01.11. | STENOCARE Change in the Board of Directors | 1 | Cision News | ||
14.10. | Stenocare A/S: STENOCARE updates guidance for 2024 | 71 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The... ► Artikel lesen | |
21.08. | STENOCARE: Interim Report Second Quarter 2024 | 2 | Cision News | ||
STENOCARE Aktie jetzt für 0€ handeln | |||||
08.08. | Danish Cannabis Company Stenocare To Launch 'Innovative' Medical Marijuana Oil In Germany | 1 | Benzinga.com | ||
31.07. | New innovative Stenocare Astrum 10-10 oil product is ready for sale in Germany | 1 | Cision News | ||
03.07. | First North Denmark: Stenocare A/S - increase in number of shares | 315 | GlobeNewswire | New shares in Stenocare A/S will be admitted to trading on Nasdaq First North
Growth Market Denmark as per 4 July 2024 due to exercise of warrants (TO 2) and
directed issue.
Name: ... ► Artikel lesen | |
28.06. | STENOCARE A/S: Directed issue, refinancing of debt from a major shareholder and new dates | 2 | Cision News | ||
25.06. | STENOCARE: TO2 Warrant Exercise subscribed to 88.3% | 1 | Cision News | ||
20.06. | STENOCARE: Notice for deadline of subscribing at the discounted price of DKK 3.16 per share | 1 | Cision News | ||
18.06. | STENOCARE A/S: Notice for deadline of trading TO2 Warrants | 1 | Cision News | ||
17.06. | STENOCARE is expanding into Canada | 1 | Cision News | ||
13.06. | STENOCARE A/S: Publication of investment brochure | 1 | Cision News | ||
12.06. | STENOCARE is shortlisted for European Cannabis Company of the Year | 1 | Cision News | ||
07.06. | STENOCARE A/S: Announcement of Exercise Price of Warrants of Series TO2 | 1 | Cision News | ||
31.05. | An Update on STENOCARE's Strong Product Pipeline | 1 | Cision News | ||
28.12.23 | First North Denmark: Stenocare A/S - increase in number of shares | 375 | GlobeNewswire | New shares in Stenocare A/S will be admitted to trading on Nasdaq First North
Growth Market Denmark as per 29 December 2023 due to a directed issue of shares
and exercise of warrants (TO 1).
Name:... ► Artikel lesen | |
30.11.23 | First North Denmark: Stenocare A/S - announcement regarding change of terms | 318 | GlobeNewswire | In continuation of the announcement from Stenocare A/S, please notice that last
trading day for Stenocare TO 1 is 15 December 2023.
Please also notice that the exercise period has been changed,... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
AURORA CANNABIS | 4,008 | -0,50 % | Aurora Cannabis Inc (3): Aurora Cannabis releases new recreational products | ||
ABBVIE | 159,86 | +0,45 % | European Commission Approves AbbVie's ELAHERE For Platinum-Resistant Ovarian Cancer Treatment | WASHINGTON (dpa-AFX) - AbbVie (ABBV) announced that the European Commission approved ELAHERE or mirvetuximab soravtansine for the treatment of adult patients with folate receptor-alpha (FR?)... ► Artikel lesen | |
CANOPY GROWTH | 3,600 | +0,98 % | Jetzt wird es brenzlig: Kurse von Tilray, Canopy & Co. brechen massiv ein. So heftig könnte es werden | © Foto: Piyapong Thongdumhyu - 123rf StockfotoRund um die US-Wahl fielen weitere Entscheidungen. Während der Cannabis-Sektor die Wahl Trumps zum nächsten US-Präsidenten noch nicht so ganz einordnen... ► Artikel lesen | |
TILRAY BRANDS | 1,233 | +0,28 % | Tilray Brands, Inc.: Tilray Medical bringt erste in Deutschland angebaute kommerzielle medizinische Cannabisprodukte unter neu erweiterter Anbaulizenz auf den Markt | NEUMÜNSTER, Deutschland, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führender Anbieter... ► Artikel lesen | |
INNOCAN PHARMA | 0,148 | +6,12 % | Innocan Pharma meldet Finanzergebnisse für das dritte Quartal 2024 | 2,7-facher Umsatzzuwachs im Jahresvergleich auf 24 Mio. US$ im Zeitraum von 9 Monaten
Herzliya, Israel und Calgary, Alberta - 20. November 2024 / IRW-Press / Innocan Pharma Corporation... ► Artikel lesen | |
TAAT GLOBAL ALTERNATIVES | 0,130 | 0,00 % | XFRA 2TP0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
DERMAPHARM | 37,250 | +0,95 % | Dermapharm: Q3-Ergebnisse: Auf gutem Weg, die Ziele für das GJ24 zu erreichen; mwb research empfiehlt KAUFEN | Die Dermapharm Holding SE (DMP) berichtete über ein solides Ergebnis für das dritte Quartal 2024. Die Umsätze stiegen im Quartal um 10 % im Vergleich zum Vorjahr, während das bereinigte EBITDA um 15... ► Artikel lesen | |
CRONOS GROUP | 1,848 | -2,89 % | Cronos Group Inc. (CRON): A Bull Case Theory | ||
SYNBIOTIC | 5,580 | -1,41 % | EQS-News: SYNBIOTIC SE: In voller Blüte: WEECO Pharma stärkt Umsatz von SYNBIOTIC | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Sonstiges
In voller Blüte: WEECO Pharma stärkt Umsatz von SYNBIOTIC
14.11.2024 / 13:30 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
TRANSCANNA | 0,017 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 02.07.2024 | The following instruments on XETRA do have their last trading day on 02.07.2024Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 02.07.2024ISIN NameGB00BMGRFP88 CITIUS RESOURCES LS-... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
ORGANIGRAM | 1,424 | +0,71 % | Organigram Reports Third Quarter Fiscal 2024 Results | TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the third quarter... ► Artikel lesen | |
CRESCO LABS | 1,184 | +4,78 % | Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results | Record quarterly operating cash flow of $49 million and year to date operating cashflow of $103 million, an increase of 66% from the prior year period
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)... ► Artikel lesen | |
GREEN THUMB INDUSTRIES | 9,000 | -1,32 % | Grünes Gold!: Gesundheit so wichtig wie nie! Medizinische Revolution durch diese Aktie! | ||
SNDL | 1,836 | -1,56 % | Cannabis company SNDL to repurchase up to CA$100 million in stock |